Literature DB >> 6309443

Defective in vitro antibody production to Varicella zoster and other virus antigens in patients with Hodgkin's disease.

R L Souhami, J Babbage, A Sigfusson.   

Abstract

Cultures of blood mononuclear cells stimulated with Varicella zoster antigen (VZA) produced specific anti-VZA antibody in 20 of 27 normal adults but only 10 of 47 patients with treated Hodgkin's disease. Serum anti-VZA antibody levels were the same in normals and patients. The deficiency of in vitro production was found in patients who had been off treatment for 6 or more years and was not related to splenectomy. Each of 11 untreated patients had absent in vitro production from blood cells but spleen cultures produced antibody readily. Using combinations of autologous spleen and blood cells, the defect was attributable to the blood B cells. Defective production was also found in response to influenza viruses and herpes simplex. We suggest that an abnormality in B cell circulation with localization of antibody producing B cells in spleen and lymph nodes, is a feature of treated and untreated Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309443      PMCID: PMC1535670     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  T and B lymphocytes and monocytes in the spleen in Hodgkin's disease: the increase in T lymphocytes in involved spleens.

Authors:  A Santoro; B Cailou; D Belpomme
Journal:  Eur J Cancer       Date:  1977 Apr-May       Impact factor: 9.162

2.  Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins.

Authors:  N R Ling; S Bishop
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

3.  In vitro splenic IgG synthesis in Hodgkin's disease.

Authors:  R L Longmire; R McMillan; R Yelenosky; S Armstrong; J E Lang; C G Craddock
Journal:  N Engl J Med       Date:  1973-10-11       Impact factor: 91.245

4.  Herpes Zoster-Varicella infections and lymphoma.

Authors:  D R Goffinet; E J Glatstein; T C Merigan
Journal:  Ann Intern Med       Date:  1972-02       Impact factor: 25.391

5.  Ecotaxis: the principle and its application to the study of Hodgkin's disease.

Authors:  M D Sousa; M Yang; E Lopes-Corrales; C Tan; J A Hansen; B Dupont; R A Good
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

6.  Specific in vitro antibody response to varicella zoster.

Authors:  R L Souhami; J Babbage; R E Callard
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

7.  Specific in vitro antibody response to influenza virus by human blood lymphocytes.

Authors:  R E Callard
Journal:  Nature       Date:  1979-12-13       Impact factor: 49.962

8.  Activation of human B lymphocytes. IV. Regulatory effects of corticosteroids on the triggering signal in the plaque-forming cell response of human peripheral blood B lymphocytes to polyclonal activation.

Authors:  A S Fauci; K R Pratt; G Whalen
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

9.  Monocyte function in Hodgkin's disease.

Authors:  G Holm; M Björkholm; B Johansson; H Mellstedt; C Lindemalm
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

10.  Spectrum of immunodeficiencies with Hodgkin's disease.

Authors:  J J Twomey; A H Laughter; L Rice; R Ford
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

View more
  8 in total

1.  Characterization of two monoclonal antibodies (UCL4D12 and UCL3D3) that discriminate between human mantle zone and marginal zone B cells.

Authors:  J Smith-Ravin; J Spencer; P C Beverley; P G Isaacson
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

2.  Intrinsic B lymphocyte defect in untreated patients with Hodgkin's disease.

Authors:  F Griesinger; L Bergmann; R Barot-Ciorbaru; P S Mitrou
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 3.  Immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  L Turner-Stokes; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

4.  Human immune responses to herpes simplex virus, varicella-zoster and cytomegalovirus in vitro.

Authors:  S A Williamson; N Parish; J D Chambers; R A Knight
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

5.  Antibody-dependent cell-mediated cytotoxicity to Varicella zoster.

Authors:  J Babbage; A Sigfusson; R L Souhami
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

6.  Varicella-zoster virus as a live vector for the expression of foreign genes.

Authors:  R S Lowe; P M Keller; B J Keech; A J Davison; Y Whang; A J Morgan; E Kieff; R W Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

7.  In vitro response to influenza immunisation by peripheral blood mononuclear cells from patients with systemic lupus erythematosus and other autoimmune diseases.

Authors:  L Turner-Stokes; G Cambridge; T Corcoran; J S Oxford; M L Snaith
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

8.  Defective in vitro antibody production in response to pokeweed mitogen and influenza antigen in patients with Hodgkin's disease.

Authors:  A Sigfusson; J W Babbage; R L Souhami
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.